Clinical Trial Update: Immune Modulation During Palynziq® Treatment in Adults (IMPALA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update (IMPALA) evaluating immune modulation during Palynziq treatment in adults with phenylketonuria; the study is currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 4 | Status: NOT_YET_RECRUITING